Advanced Enzyme Technologies Limited (ADVENZYMES) — FY26 Annual Report | 8 July 2026(2 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Annual Report 🔴 High Importance Neutral 📄 PDF

Advanced Enzyme Technologies announced that shareholders without registered email addresses will receive a link and QR code to access the Integrated Annual Report for FY 2025-26 and the notice for its 37th Annual General Meeting scheduled for July 31, 2026, via video conference, as required under SEBI Regulation 36(1)(b).

2 Annual Report 🔴 High Importance Neutral 📄 PDF

Advanced Enzyme Technologies Limited announced its 37th Annual General Meeting on July 31, 2026, via video conference, to transact ordinary and special business including approval of audited standalone and consolidated financial statements for FY2025-26, final dividend of ₹1.35 per share, reappointment of directors Mukund Kabra and Pradip Shah, reappointment of statutory auditors MSKA & Associates LLP for a second 5-year term, and approval of material related party transactions with JC Biotech Private Limited. The meeting will be conducted electronically with remote e-voting facilities provided through NSDL, and shareholders must update KYC details to receive dividends electronically.

About Advanced Enzyme Technologies Limited (ADVENZYMES)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,071.34 Cr P/E: 24.1 ROE: 10.3% ROCE: 13.8%

View full ADVENZYMES stock details →

📡 Get AI alerts when ADVENZYMES files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ADVENZYMES — Free

📊 More ADVENZYMES filings

See all ADVENZYMES filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ADVENZYMES files new disclosures

Track ADVENZYMES filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ADVENZYMES — Free

Free account · 2 AI queries/day